Pharmather

PharmaTher Provides Business Highlights And Releases Audited Annual Financials

PharmaTher Granted Orphan Drug Designation for Life-Saving Seizure Medicine

Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022

PharmaTher Granted Orphan Drug Designation for Life-Saving Seizure Medicine

Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022

FDA Approves PharmaTher's Phase 2 Trial For Ketamine ALS Treatment

Psyched: MindMed and Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Gets Back To Trading

FDA Approves PharmaTher's Phase 2 Trial For Ketamine ALS Treatment

Psyched: MindMed and Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Gets Back To Trading

Cannabis Movers & Shakers: Newscope Capital, Mr. Cannabis Law, CannTrust, Nabis, AMMJ, Plus Products, Christina Lake

Psyched: The First Psychedelics ETF, Beckley Raises $19M, 3 Companies Go Public

Pharmather Recent News

'Psyched': Study Finds MDMA More Cost-Effective Than Traditional PTSD Treatments, Pharmather Goes Public

MDMA-assisted psychotherapy would result significantly more cost-effective than current available treatment options for post-traumatic stress disorder, according to a study distributed by the Multidisciplinary Association for Psychedelic Studies.